Stockscreener 앱 받기
3.05
0.00%
0.00
전일 마감가:
$3.05
열려 있는:
$3.03
하루 거래량:
46,632
Relative Volume:
0.20
시가총액:
$159.74M
수익:
$81.06M
순이익/손실:
$-55.55M
주가수익비율:
-2.6754
EPS:
-1.14
순현금흐름:
$-47.98M
1주 성능:
-1.29%
1개월 성능:
+32.61%
6개월 성능:
-35.24%
1년 성능:
-48.83%
1일 변동 폭
$3.02
$3.15
1주일 범위
$2.91
$3.26
52주 변동 폭
$2.03
$8.45
Sight Sciences Inc Stock (SGHT) Company Profile
명칭
Sight Sciences Inc
전화
(415) 889-0550
주소
4040 CAMPBELL AVE,, MENLO PARK
SGHT을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SGHT
Sight Sciences Inc
|
3.05 | 159.74M | 81.06M | -55.55M | -47.98M | -1.14 |
|
ABT
Abbott Laboratories
|
132.25 | 224.65B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
104.48 | 151.13B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
382.11 | 139.34B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
83.44 | 108.80B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
75.37 | 44.25B | 5.54B | 4.18B | 259.90M | 7.00 |
Sight Sciences Inc Stock (SGHT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-12-06 | 개시 | UBS | Buy |
| 2024-11-04 | 다운그레이드 | Lake Street | Buy → Hold |
| 2024-08-21 | 개시 | Lake Street | Buy |
| 2023-09-12 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2023-09-12 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2023-09-12 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2023-08-24 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2023-07-10 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2023-01-06 | 업그레이드 | Stifel | Hold → Buy |
| 2022-10-04 | 개시 | Needham | Hold |
| 2022-07-26 | 개시 | Stifel | Hold |
| 2022-02-03 | 개시 | William Blair | Outperform |
| 2022-01-07 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
모두보기
Sight Sciences Inc 주식(SGHT)의 최신 뉴스
Sight Sciences, Inc. (NASDAQ:SGHT) Receives Average Recommendation of “Hold” from Analysts - Defense World
Sight Sciences, Inc. (NASDAQ:SGHT) Shares Bought by JPMorgan Chase & Co. - Defense World
Head to Head Survey: Pulse Biosciences (NASDAQ:PLSE) & Sight Sciences (NASDAQ:SGHT) - Defense World
Sight Sciences, Inc. (NASDAQ:SGHT) Shares Acquired by Renaissance Technologies LLC - Defense World
Geode Capital Management LLC Boosts Stock Position in Sight Sciences, Inc. (NASDAQ:SGHT) - Defense World
Sight Sciences to Report First Quarter 2025 Financial Results on May 8, 2025 - The Manila Times
Sight Sciences, Inc. to Report First Quarter Financial Results on May 8, 2025 - Nasdaq
Eyecare Tech Leader Sight Sciences Sets Q1 2025 Earnings Date: What Investors Should Watch - Stock Titan
Sight Sciences (SGHT) to Release Earnings on Thursday - Defense World
Sight Sciences stock hits 52-week low at $2.54 amid market challenges - MSN
Sight Sciences Announces the Release of its Sustainability Report - GlobeNewswire
Sight Sciences Sustainability Report Reveals Strong Gender Pay Equity, 14% Staff Retention Boost - Stock Titan
Sight Sciences Appoints Gary Burbach to Board of Directors - VisionMonday.com
Sight Sciences appoints new board member By Investing.com - Investing.com India
Sight Sciences appoints new board member - Investing.com Australia
Sight Sciences Appoints Gary Burbach to its Board of Directors - The Manila Times
Sight Sciences Strengthens Board with Medtech Veteran as Glaucoma, Dry Eye Markets Transform - Stock Titan
Sight Sciences Launches OMNI® Edge Surgical System to Enhance Glaucoma Treatment - Nasdaq
Sight Sciences to Debut OMNI® Edge Surgical System at the - GlobeNewswire
Sight Sciences Unveils OMNI Edge: Next-Gen Glaucoma Surgery System with 2X Capacity | SGHT Stock News - Stock Titan
Sight Sciences, Inc. (NASDAQ:SGHT) Shares Acquired by American Century Companies Inc. - Defense World
Sight Sciences (NASDAQ:SGHT) Earns Hold Rating from Needham & Company LLC - Defense World
Sight sciences CTO David Badawi sells $15,081 in stock - MSN
April 2025's Top Penny Stocks To Watch - simplywall.st
Sight Sciences, Inc. (NASDAQ:SGHT) Given Consensus Recommendation of “Hold” by Analysts - Defense World
Sight Sciences at 24th Annual Needham Conference: Strategic Growth Insights - Investing.com Canada
Sight sciences chief commercial officer sells $11,641 in stock By Investing.com - Investing.com India
Sight Sciences stock hits 52-week low at $2.13 amid market challenges - Investing.com
Sight sciences chief commercial officer sells $11,641 in stock - Investing.com
Sight sciences CEO Paul Badawi sells shares worth $55,672 By Investing.com - Investing.com Australia
Sight sciences CTO David Badawi sells $13,771 in common stock By Investing.com - Investing.com India
Sight Sciences CFO Alison Bauerlein sells shares worth $44,787 By Investing.com - Investing.com Australia
Sight Sciences CFO Alison Bauerlein sells shares worth $44,787 - Investing.com
Sight sciences CTO David Badawi sells $13,771 in common stock - Investing.com
Sight Sciences chief legal officer sells $21,693 in stock - Investing.com
Sight Sciences chief legal officer sells $21,693 in stock By Investing.com - Investing.com UK
Sight Sciences Executives Sell Shares to Cover Tax Liabilities - TradingView
Sight Sciences stock hits 52-week low at $2.13 amid market challenges By Investing.com - Investing.com South Africa
Sight Sciences, Inc. (NASDAQ:SGHT) Short Interest Update - Defense World
Charles Schwab Investment Management Inc. Raises Stock Position in Sight Sciences, Inc. (NASDAQ:SGHT) - Defense World
Sight Sciences, Inc. (NASDAQ:SGHT) Looks Inexpensive But Perhaps Not Attractive Enough - simplywall.st
Sight sciences chief legal officer sells shares worth $19,250 - MSN
Sight Sciences to Present at the 24th Annual Needham Healthcare Conference on April 8th - GlobeNewswire
Key Investor Updates Coming: Sight Sciences Takes Center Stage at Major Healthcare Conference - Stock Titan
RxSight, Inc. to Participate in the 24th Annual Needham Virtual Healthcare Conference - The Manila Times
Sight sciences EVP Manohar Raheja buys $53,250 in stock By Investing.com - Investing.com Australia
Sight sciences EVP Manohar Raheja buys $53,250 in stock - Investing.com India
Sight Sciences Inc (SGHT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
10.11%
0.04%
자본화:
|
볼륨(24시간):